Barbara Shepherd Selected Research

AERAS-402

1/2017	Safety and Immunogenicity of Adenovirus 35 Tuberculosis Vaccine Candidate in Adults with Active or Previous Tuberculosis. A Randomized Trial.
1/2016	Adenovirus type 35-vectored tuberculosis vaccine has an acceptable safety and tolerability profile in healthy, BCG-vaccinated, QuantiFERON(®)-TB Gold (+) Kenyan adults without evidence of tuberculosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Barbara Shepherd Research Topics

Disease

3	Tuberculosis (Tuberculoses) 01/2019 - 01/2016
1	Hematuria 01/2017
1	Neutropenia 01/2016
1	Pain (Aches) 01/2016
1	Infections 01/2016

Drug/Important Bio-Agent (IBA)

3	VaccinesIBA 01/2019 - 01/2016
2	AERAS-402IBA 01/2017 - 01/2016
2	Tuberculosis VaccinesIBA 01/2017 - 01/2016
1	Creatine Kinase (Creatine Phosphokinase)IBA 01/2016
1	Immunodominant EpitopesIBA 01/2016
1	GoldIBA 01/2016